Ribosome biogenesis in skeletal development and the pathogenesis of skeletal disorders

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 6, 2014, Pages 769-778

  Trainor, Paul A ^a,b   Merrill, Amy E ^c,d  

^a STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cartilage hair hypoplasia; Ribosome biogenesis; Roberts syndrome; Shwachman Diamond syndrome; Skeletal development; Treacher Collins syndrome

Indexed keywords

BIOGENESIS; BLACKFAN DIAMOND ANEMIA; BONE DEVELOPMENT; BONE DISEASE; BOWEN CONRADI SYNDROME; CALCIFYING CHONDRODYSTROPHY; CARTILAGE HAIR HYPOPLASIA; CARTILAGE HYPOPLASIA; DYSOSTOSIS; HUMAN; MANDIBULOFACIAL DYSOSTOSIS; NONHUMAN; PATHOGENESIS; POSTAXIAL ACROFACIAL DYSOSTOSIS; PRIORITY JOURNAL; REVIEW; RIBOSOME; ROBERTS SYNDROME; SHWACHMAN SYNDROME; BONE DYSPLASIA; BONE MARROW DISEASE; GENETICS; HAIR; HIRSCHSPRUNG DISEASE; IMMUNE DEFICIENCY; LIPOMATOSIS; METABOLISM; OSTEOCHONDRODYSPLASIAS; PANCREAS EXOCRINE INSUFFICIENCY; PATHOLOGY; PATHOPHYSIOLOGY; SKELETON;

VERTEBRATA;

MESSENGER RNA;

ANEMIA, DIAMOND-BLACKFAN; BONE DEVELOPMENT; BONE DISEASES, DEVELOPMENTAL; BONE MARROW DISEASES; EXOCRINE PANCREATIC INSUFFICIENCY; HAIR; HIRSCHSPRUNG DISEASE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LIPOMATOSIS; MANDIBULOFACIAL DYSOSTOSIS; OSTEOCHONDRODYSPLASIAS; RIBOSOMES; RNA, MESSENGER; SKELETON;

EID: 84897038174     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.11.010     Document Type: Review

References (137)

1. Stoll C., Dott B., Roth M.P., Alembik Y. Birth prevalence rates of skeletal dysplasias. Clin. Genet. 1989, 35:88-92.
2. Lafontaine D.L.J., Tollervey D. The function and synthesis of ribosomes. Nat. Rev. Mol. Cell Biol. 2001, 2:514-520.
3. Kressler D., Hurt E., Baβler J. Driving ribosome assembly. Biochim. Biophys. Acta (BBA) - Mol. Cell Res. 2010, 1803:673-683.
4. Laferte A., Favry E., Sentenac A., Riva M., Carles C., Chedin S. The transcriptional activity of RNA polymerase I is a key determinant for the level of all ribosome components. Genes Dev. 2006, 20:2030-2040.
5. Moss T., Stefanovsky V., Langlois F., Gagnon-Kugler T. A new paradigm for the regulation of the mammalian ribosomal RNA genes. Biochem. Soc. Trans. 2006, 34:1079-1081.
6. Tschochner H., Hurt E. Pre-ribosomes on the road from the nucleolus to the cytoplasm. Trends Cell Biol. 2003, 13:255-263.
7. Jorgensen P., Rupes I., Sharom J.R., Schneper L., Broach J.R., Tyers M. A dynamic transcriptional network communicates growth potential to ribosome synthesis and critical cell size. Genes Dev. 2004, 18:2491-2505.
8. Karsenty G., Kronenberg H.M., Settembre C. Genetic control of bone formation. Annu. Rev. Cell Dev. Biol. 2009, 25:629-648.
9. Lefebvre V., Bhattaram P. Vertebrate skeletogenesis. Curr. Top. Dev. Biol. 2010, 90:291-317.
10. Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat. Rev. Mol. Cell Biol. 2012, 13:27-38.
11. Long F., Ornitz D.M. Development of the endochondral skeleton. Cold Spring Harb. Perspect. Biol. 2013, 5:a008334.
12. Smits P., Li P., Mandel J., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B., Lefebvre V. The transcription factors l-Sox5 and Sox6 are essential for cartilage formation. Dev. Cell 2001, 1:277-290.
13. Bi W., Huang W., Whitworth D.J., Deng J.M., Zhang Z., Behringer R.R., de Crombrugghe B. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:6698-6703.
14. Arnold M.A., Kim Y., Czubryt M.P., Phan D., McAnally J., Qi X., Shelton J.M., Richardson J.A., Bassel-Duby R., Olson E.N. MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev. Cell 2007, 12:377-389.
15. Inada M., Yasui T., Nomura S., Miyake S., Deguchi K., Himeno M., Sato M., Yamagiwa H., Kimura T., Yasui N., Ochi T., Endo N., Kitamura Y., Kishimoto T., Komori T. Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev. Dyn. 1999, 214:279-290.
16. Kim I.S., Otto F., Zabel B., Mundlos S. Regulation of chondrocyte differentiation by Cbfa1. Mech. Dev. 1999, 80:159-170.
17. Young D.W., Hassan M.Q., Yang X.Q., Galindo M., Javed A., Zaidi S.K., Furcinitti P., Lapointe D., Montecino M., Lian J.B., Stein J.L., van Wijnen A.J., Stein G.S. Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:3189-3194.
18. Ali S.A., Dobson J.R., Lian J.B., Stein J.L., van Wijnen A.J., Zaidi S.K., Stein G.S. A RUNX2-HDAC1 co-repressor complex regulates rRNA gene expression by modulating UBF acetylation. J. Cell Sci. 2012, 125:2732-2739.
19. Pande S., Ali S.A., Dowdy C., Zaidi S.K., Ito K., Ito Y., Montecino M.A., Lian J.B., Stein J.L., van Wijnen A.J., Stein G.S. Subnuclear targeting of the Runx3 tumor suppressor and its epigenetic association with mitotic chromosomes. J. Cell. Physiol. 2009, 218:473-479.
20. Hannan R.D., Stefanovsky V., Taylor L., Moss T., Rothblum L.I. Overexpression of the transcription factor UBF1 is sufficient to increase ribosomal DNA transcription in neonatal cardiomyocytes: implications for cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:8750-8755.
21. Wan M., Cao X. BMP signaling in skeletal development. Biochem. Biophys. Res. Commun. 2005, 328:651-657.
22. Ornitz D.M., Marie P.J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 2002, 16:1446-1465.
23. Yoshida C.A., Yamamoto H., Fujita T., Furuichi T., Ito K., Inoue K., Yamana K., Zanma A., Takada K., Ito Y., Komori T. Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev. 2004, 18:952-963.
24. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
25. Yang X., Matsuda K., Bialek P., Jacquot S., Masuoka H.C., Schinke T., Li L., Brancorsini S., Sassone-Corsi P., Townes T.M., Hanauer A., Karsenty G. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 2004, 117:387-398.
26. Eilbracht J., Reichenzeller M., Hergt M., Schnolzer M., Heid H., Stohr M., Franke W.W., Schmidt-Zachmann M.S. NO66, a highly conserved dual location protein in the nucleolus and in a special type of synchronously replicating chromatin. Mol. Biol. Cell 2004, 15:1816-1832.
27. Sinha K.M., Yasuda H., Coombes M.M., Dent S.Y., de Crombrugghe B. Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase. EMBO J. 2010, 29:68-79.
28. Pratap J., Galindo M., Zaidi S.K., Vradii D., Bhat B.M., Robinson J.A., Choi J.Y., Komori T., Stein J.L., Lian J.B., Stein G.S., van Wijnen A.J. Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts. Cancer Res. 2003, 63:5357-5362.
29. Galindo M., Pratap J., Young D.W., Hovhannisyan H., Im H.J., Choi J.Y., Lian J.B., Stein J.L., Stein G.S., van Wijnen A.J. The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts. J. Biol. Chem. 2005, 280:20274-20285.
30. Ali S.A., Zaidi S.K., Dacwag C.S., Salma N., Young D.W., Shakoori A.R., Montecino M.A., Lian J.B., van Wijnen A.J., Imbalzano A.N., Stein G.S., Stein J.L. Phenotypic transcription factors epigenetically mediate cell growth control. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6632-6637.
31. Zaidi S.K., Javed A., Choi J.Y., van Wijnen A.J., Stein J.L., Lian J.B., Stein G.S. A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J. Cell Sci. 2001, 114:3093-3102.
32. Treacher Collins E. Case with symmetrical congenital notches in the outer part of each lower lid and defective development of the malar bones. Trans. Ophthalmol. Soc. U. K. 1900, 20:90.
33. Franceschetti A., Klein D. The mandibulofacial dysostosis; a new hereditary syndrome. Acta Ophthalmol. (Copenh) 1949, 27:143-224.
34. Poswillo D. The pathogenesis of the Treacher Collins syndrome (mandibulofacial dysostosis). Br. J. Oral. Surg. 1975, 13:1-26.
35. Stovin J.J., Lyon J.A., Clemmens R.L. Mandibulofacial dysostosis. Radiology 1960, 74:225-231.
36. Cohen J., Ghezzi F., Goncalves L., Fuentes J.D., Paulyson K.J., Sherer D.M. Prenatal sonographic diagnosis of Treacher Collins syndrome: a case and review of the literature. Am. J. Perinatol. 1995, 12:416-419.
37. Milligan D.A., Harlass F.E., Duff P., Kopelman J.N. Recurrence of Treacher Collins' syndrome with sonographic findings. Mil. Med. 1994, 159:250-252.
38. Teber O.A., Gillessen-Kaesbach G., Fischer S., Bohringer S., Albrecht B., Albert A., Arslan-Kirchner M., Haan E., Hagedorn-Greiwe M., Hammans C., Henn W., Hinkel G.K., Konig R., Kunstmann E., Kunze J., Neumann L.M., Prott E.C., Rauch A., Rott H.D., Seidel H., Spranger S., Sprengel M., Zoll B., Lohmann D.R., Wieczorek D. Genotyping in 46 patients with tentative diagnosis of Treacher Collins syndrome revealed unexpected phenotypic variation. Eur. J. Hum. Genet. 2004, 12:879-890.
39. Sakai D., Dixon J., Dixon M.J., Trainor P.A. Mammalian neurogenesis requires Treacle-Plk1 for precise control of spindle orientation, mitotic progression, and maintenance of neural progenitor cells. PLoS Genet. 2012, 8:e1002566.
40. Treacher Collins Syndrome Collaborative Group Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome. Nat. Genet. 1996, 12:130-136.
41. Dauwerse J.G., Dixon J., Seland S., Ruivenkamp C.A., van Haeringen A., Hoefsloot L.H., Peters D.J., Boers A.C., Daumer-Haas C., Maiwald R., Zweier C., Kerr B., Cobo A.M., Toral J.F., Hoogeboom A.J., Lohmann D.R., Hehr U., Dixon M.J., Breuning M.H., Wieczorek D. Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat. Genet. 2011, 43:20-22.
42. Dixon M.J., Marres H.A., Edwards S.J., Dixon J., Cremers C.W. Treacher Collins syndrome: correlation between clinical and genetic linkage studies. Clin. Dysmorphol. 1994, 3:96-103.
43. Marres H.A., Cremers C.W., Dixon M.J., Huygen P.L., Joosten F.B. The Treacher Collins syndrome. A clinical, radiological, and genetic linkage study on two pedigrees. Arch. Otolaryngol. Head Neck Surg. 1995, 121:509-514.
44. Edwards S.J., Gladwin A.J., Dixon M.J. The mutational spectrum in Treacher Collins syndrome reveals a predominance of mutations that create a premature-termination codon. Am. J. Hum. Genet. 1997, 60:515-524.
45. Gladwin A.J., Dixon J., Loftus S.K., Edwards S., Wasmuth J.J., Hennekam R.C., Dixon M.J. Treacher Collins syndrome may result from insertions, deletions or splicing mutations, which introduce a termination codon into the gene. Hum. Mol. Genet. 1996, 5:1533-1538.
46. Isaac C., Marsh K.L., Paznekas W.A., Dixon J., Dixon M.J., Jabs E.W., Meier U.T. Characterization of the nucleolar gene product, treacle, in Treacher Collins syndrome. Mol. Biol. Cell 2000, 11:3061-3071.
47. Splendore A., Silva E.O., Alonso L.G., Richieri-Costa A., Alonso N., Rosa A., Carakushanky G., Cavalcanti D.P., Brunoni D., Passos-Bueno M.R. High mutation detection rate in TCOF1 among Treacher Collins syndrome patients reveals clustering of mutations and 16 novel pathogenic changes. Hum. Mutat. 2000, 16:315-322.
48. Dixon J., Dixon M.J. Genetic background has a major effect on the penetrance and severity of craniofacial defects in mice heterozygous for the gene encoding the nucleolar protein Treacle. Dev. Dyn. 2004, 229:907-914.
49. Valdez B.C., Henning D., So R.B., Dixon J., Dixon M.J. The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10709-10714.
50. Hayano T., Yanagida M., Yamauchi Y., Shinkawa T., Isobe T., Takahashi N. Proteomic analysis of human Nop56p-associated pre-ribosomal ribonucleoprotein complexes. Possible link between Nop56p and the nucleolar protein treacle responsible for Treacher Collins syndrome. J. Biol. Chem. 2003, 278:34309-34319.
51. Dixon J., Jones N.C., Sandell L.L., Jayasinghe S.M., Crane J., Rey J.P., Dixon M.J., Trainor P.A. Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:13403-13408.
52. Jones N.C., Lynn M.L., Gaudenz K., Sakai D., Aoto K., Rey J.P., Glynn E.F., Ellington L., Du C., Dixon J., Dixon M.J., Trainor P.A. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat. Med. 2008, 14:125-133.
53. Genee E. An extensive form of mandibulo-facial dysostosis. J. Genet. Hum. 1969, 17:45-52.
54. Miller M., Fineman R., Smith D.W. Postaxial acrofacial dysostosis syndrome. J. Pediatr. 1979, 95:970-975.
55. Wiedemann H.R. Malformation-retardation syndrome with bilateral absence of the 5th rays in both hands and feets, cleft palate, malformed ears and eyelids, radioulnar synostosis (author's transl). Klin. Padiatr. 1973, 185:181-186.
56. Ng S.B., Buckingham K.J., Lee C., Bigham A.W., Tabor H.K., Dent K.M., Huff C.D., Shannon P.T., Jabs E.W., Nickerson D.A., Shendure J., Bamshad M.J. Exome sequencing identifies the cause of a mendelian disorder. Nat. Genet. 2010, 42:30-35.
57. Rainger J., Bengani H., Campbell L., Anderson E., Sokhi K., Lam W., Riess A., Ansari M., Smithson S., Lees M., Mercer C., McKenzie K., Lengfeld T., Gener Querol B., Branney P., McKay S., Morrison H., Medina B., Robertson M., Kohlhase J., Gordon C., Kirk J., Wieczorek D., Fitzpatrick D.R. Miller (Genee-Wiedemann) syndrome represents a clinically and biochemically distinct subgroup of postaxial acrofacial dysostosis associated with partial deficiency of DHODH. Hum. Mol. Genet. 2012, 21:3969-3983.
58. White R.M., Cech J., Ratanasirintrawoot S., Lin C.Y., Rahl P.B., Burke C.J., Langdon E., Tomlinson M.L., Mosher J., Kaufman C., Chen F., Long H.K., Kramer M., Datta S., Neuberg D., Granter S., Young R.A., Morrison S., Wheeler G.N., Zon L.I. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 2011, 471:518-522.
59. Lipton J.M., Ellis S.R. Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis. Hematol. Oncol. Clin. North Am. 2009, 23:261-282.
60. Narla A., Ebert B.L. Ribosomopathies: human disorders of ribosome dysfunction. Blood 2010, 115:3196-3205.
61. Gazda H.T., Sheen M.R., Vlachos A., Choesmel V., O'Donohue M.-F., Schneider H., Darras N., Hasman C., Sieff C.A., Newburger P.E., Ball S.E., Niewiadomska E., Matysiak M., Zaucha J.M., Glader B., Niemeyer C., Meerpohl J.J., Atsidaftos E., Lipton J.M., Gleizes P.-E., Beggs A.H. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am. J. Hum. Genet. 2008, 83:769-780.
62. Danilova N., Sakamoto K.M., Lin S. Ribosomal protein L11 mutation in zebrafish leads to haematopoietic and metabolic defects. Br. J. Haematol. 2011, 152:217-228.
63. Chakraborty A., Uechi T., Higa S., Torihara H., Kenmochi N. Loss of ribosomal protein L11 affects zebrafish embryonic development through a p53-dependent apoptotic response. PLoS ONE 2009, 4:e4152.
64. Jaako P., Flygare J., Olsson K., Quere R., Ehinger M., Henson A., Ellis S., Schambach A., Baum C., Richter J., Larsson J., Bryder D., Karlsson S. Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia. Blood 2011, 118:6087-6096.
65. Danilova N., Sakamoto K.M., Lin S. Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood 2008, 112:5228-5237.
66. Payne E.M., Virgilio M., Narla A., Sun H., Levine M., Paw B.H., Berliner N., Look A.T., Ebert B.L., Khanna-Gupta A. l-leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway. Blood 2012, 120:2214-2224.
67. Jaako P., Debnath S., Olsson K., Bryder D., Flygare J., Karlsson S. Dietary l-leucine improves the anemia in a mouse model for Diamond-Blackfan anemia. Blood 2012, 120:2225-2228.
68. Cmejlova J., Dolezalova L., Pospisilova D., Petrtylova K., Petrak J., Cmejla R. Translational efficiency in patients with Diamond-Blackfan anemia. Haematologica 2006, 91:1456-1464.
69. Pospisilova D., Cmejlova J., Hak J., Adam T., Cmejla R. Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine. Haematologica 2007, 92:e66-e67.
70. Bonfils G., Jaquenoud M., Bontron S., Ostrowicz C., Ungermann C., De Virgilio C. Leucyl-tRNA synthetase controls TORC1 via the EGO complex. Mol. Cell 2012, 46:105-110.
71. Hannan K.M., Brandenburger Y., Jenkins A., Sharkey K., Cavanaugh A., Rothblum L., Moss T., Poortinga G., McArthur G.A., Pearson R.B., Hannan R.D. mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF†. Mol. Cell. Biol. 2003, 23:8862-8877.
72. Mayer C., Zhao J., Yuan X., Grummt I. mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. Genes Dev. 2004, 18:423-434.
73. Powers T., Walter P. Regulation of ribosome biogenesis by the rapamycin-sensitive TOR-signaling pathway in Saccharomyces cerevisiae. Mol. Biol. Cell 1999, 10:987-1000.
74. Wei Y., Tsang C.K., Zheng X.F.S. Mechanisms of regulation of RNA polymerase III-dependent transcription by TORC1. EMBO J. 2009, 28:2220-2230.
75. Michels A.A., Robitaille A.M., Buczynski-Ruchonnet D., Hodroj W., Reina J.H., Hall M.N., Hernandez N. mTORC1 directly phosphorylates and regulates human MAF1. Mol. Cell. Biol. 2010, 30:3749-3757.
76. Van Den Berg D.J., Francke U. Roberts syndrome: a review of 100 cases and a new rating system for severity. Am. J. Med. Genet. 1993, 47:1104-1123.
77. Vega H., Waisfisz Q., Gordillo M., Sakai N., Yanagihara I., Yamada M., van Gosliga D., Kayserili H., Xu C., Ozono K., Wang Jabs E., Inui K., Joenje H. Roberts syndrome is caused by mutations in ESCO2, a human homolog of yeast ECO1 that is essential for the establishment of sister chromatid cohesion. Nat. Genet. 2005, 37:468-470.
78. Bose T., Lee K.K., Lu S., Xu B., Harris B., Slaughter B., Unruh J., Garrett A., McDowell W., Box A., Li H., Peak A., Ramachandran S., Seidel C., Gerton J.L. Cohesin proteins promote ribosomal RNA production and protein translation in yeast and human cells. PLoS Genet. 2012, 8:e1002749.
79. Nasmyth K., Haering C.H. Cohesin: its roles and mechanisms. Annu. Rev. Genet. 2009, 43:525-558.
80. Dorsett D., Strom L. The ancient and evolving roles of cohesin in gene expression and DNA repair. Curr. Biol. 2012, 22:R240-R250.
81. Mönnich M., Kuriger Z., Print C.G., Horsfield J.A. A zebrafish model of Roberts syndrome reveals that Esco2 depletion interferes with development by disrupting the cell cycle. PLoS ONE 2011, 6:e20051.
82. Gerton J.L. Translational mechanisms at work in the cohesinopathies. Nucleus 2012, 3:520-525.
83. Shwachman H., Diamond L.K., Oski F.A., Khaw K.T. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J. Pediatr. 1964, 65:645-663.
84. Ginzberg H., Shin J., Ellis L., Morrison J., Ip W., Dror Y., Freedman M., Heitlinger L.A., Belt M.A., Corey M., Rommens J.M., Durie P.R. Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J. Pediatr. 1999, 135:81-88.
85. Aggett P.J., Cavanagh N.P., Matthew D.J., Pincott J.R., Sutcliffe J., Harries J.T. Shwachman's syndrome. A review of 21 cases. Arch. Dis. Child. 1980, 55:331-347.
86. Makitie O., Ellis L., Durie P.R., Morrison J.A., Sochett E.B., Rommens J.M., Cole W.G. Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS. Clin. Genet. 2004, 65:101-112.
87. Boocock G.R., Morrison J.A., Popovic M., Richards N., Ellis L., Durie P.R., Rommens J.M. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat. Genet. 2003, 33:97-101.
88. Zhang S., Shi M., Hui C.C., Rommens J.M. Loss of the mouse ortholog of the Shwachman-Diamond syndrome gene (Sbds) results in early embryonic lethality. Mol. Cell. Biol. 2006, 26:6656-6663.
89. Austin K.M., Leary R.J., Shimamura A. The Shwachman-Diamond SBDS protein localizes to the nucleolus. Blood 2005, 106:1253-1258.
90. Wessels D., Srikantha T., Yi S., Kuhl S., Aravind L., Soll D.R. The Shwachman-Bodian-Diamond syndrome gene encodes an RNA-binding protein that localizes to the pseudopod of Dictyostelium amoebae during chemotaxis. J. Cell Sci. 2006, 119:370-379.
91. Leung R., Cuddy K., Wang Y., Rommens J., Glogauer M. Sbds is required for Rac2-mediated monocyte migration and signaling downstream of RANK during osteoclastogenesis. Blood 2011, 117:2044-2053.
92. Ambekar C., Das B., Yeger H., Dror Y. SBDS-deficiency results in deregulation of reactive oxygen species leading to increased cell death and decreased cell growth. Pediatr. Blood Cancer 2010, 55:1138-1144.
93. Austin K.M., Gupta M.L., Coats S.A., Tulpule A., Mostoslavsky G., Balazs A.B., Mulligan R.C., Daley G., Pellman D., Shimamura A. Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. J. Clin. Invest. 2008, 118:1511-1518.
94. Menne T.F., Goyenechea B., Sanchez-Puig N., Wong C.C., Tonkin L.M., Ancliff P.J., Brost R.L., Costanzo M., Boone C., Warren A.J. The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast. Nat. Genet. 2007, 39:486-495.
95. Moore J.B.t., Farrar J.E., Arceci R.J., Liu J.M., Ellis S.R. Distinct ribosome maturation defects in yeast models of Diamond-Blackfan anemia and Shwachman-Diamond syndrome. Haematologica 2010, 95:57-64.
96. Ganapathi K.A., Austin K.M., Lee C.S., Dias A., Malsch M.M., Reed R., Shimamura A. The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA. Blood 2007, 110:1458-1465.
97. Rujkijyanont P., Adams S.L., Beyene J., Dror Y. Bone marrow cells from patients with Shwachman-Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing. Br. J. Haematol. 2009, 145:806-815.
98. Finch A.J., Hilcenko C., Basse N., Drynan L.F., Goyenechea B., Menne T.F., Gonzalez Fernandez A., Simpson P., D'Santos C.S., Arends M.J., Donadieu J., Bellanne-Chantelot C., Costanzo M., Boone C., McKenzie A.N., Freund S.M., Warren A.J. Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev. 2011, 25:917-929.
99. Wong T.E., Calicchio M.L., Fleming M.D., Shimamura A., Harris M.H. SBDS protein expression patterns in the bone marrow. Pediatr. Blood Cancer 2010, 55:546-549.
100. Wong C.C., Traynor D., Basse N., Kay R.R., Warren A.J. Defective ribosome assembly in Shwachman-Diamond syndrome. Blood 2011, 118:4305-4312.
101. McKusick V.A., Eldridge R., Hostetler J.A., Ruangwit U., Egeland J.A. Dwarfism in the Amish. Ii. Cartilage-hair hypoplasia. Bull. Johns Hopkins Hosp. 1965, 116:285-326.
102. Makitie O., Kaitila I. Cartilage-hair hypoplasia-clinical manifestations in 108 Finnish patients. Eur. J. Pediatr. 1993, 152:211-217.
103. Makitie O., Marttinen E., Kaitila I. Skeletal growth in cartilage-hair hypoplasia. A radiological study of 82 patients. Pediatr. Radiol. 1992, 22:434-439.
104. Spranger J.W., Zabel B., Kennedy J., Jackson G., Briggs M. A disorder resembling pseudoachondroplasia but without COMP mutation. Am. J. Med. Genet. A 2005, 132A:20-24.
105. McKusick V.A. Metaphyseal dysostosis and thin hair: a "new" recessively inherited syndrome?. Lancet 1964, 1:832-833.
106. McKusick V.A., Bias W.B., Norum R.A., Cross H.E. Blood groups in two Amish demes. Humangenetik 1967, 5:36-41.
107. Hermanns P., Bertuch A.A., Bertin T.K., Dawson B., Schmitt M.E., Shaw C., Zabel B., Lee B. Consequences of mutations in the non-coding RMRP RNA in cartilage-hair hypoplasia. Hum. Mol. Genet. 2005, 14:3723-3740.
108. Ridanpaa M., van Eenennaam H., Pelin K., Chadwick R., Johnson C., Yuan B., vanVenrooij W., Pruijn G., Salmela R., Rockas S., Makitie O., Kaitila I., de la Chapelle A. Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell 2001, 104:195-203.
109. Ridanpaa M., Sistonen P., Rockas S., Rimoin D.L., Makitie O., Kaitila I. Worldwide mutation spectrum in cartilage-hair hypoplasia: ancient founder origin of the major70A->G mutation of the untranslated RMRP. Eur. J. Hum. Genet. 2002, 10:439-447.
110. Welting T.J., van Venrooij W.J., Pruijn G.J. Mutual interactions between subunits of the human RNase MRP ribonucleoprotein complex. Nucleic Acids Res. 2004, 32:2138-2146.
111. Gill T., Cai T., Aulds J., Wierzbicki S., Schmitt M.E. RNase MRP cleaves the CLB2 mRNA to promote cell cycle progression: novel method of mRNA degradation. Mol. Cell. Biol. 2004, 24:945-953.
112. Schmitt M.E., Clayton D.A. Nuclear RNase MRP is required for correct processing of pre-5.8S rRNA in Saccharomyces cerevisiae. Mol. Cell. Biol. 1993, 13:7935-7941.
113. Henry Y., Wood H., Morrissey J.P., Petfalski E., Kearsey S., Tollervey D. The 5' end of yeast 5.8S rRNA is generated by exonucleases from an upstream cleavage site. EMBO J. 1994, 13:2452-2463.
114. Shadel G.S., Buckenmeyer G.A., Clayton D.A., Schmitt M.E. Mutational analysis of the RNA component of Saccharomyces cerevisiae RNase MRP reveals distinct nuclear phenotypes. Gene 2000, 245:175-184.
115. Zhao Y., Sohn J.H., Warner J.R. Autoregulation in the biosynthesis of ribosomes. Mol. Cell. Biol. 2003, 23:699-707.
116. Thiel C.T., Horn D., Zabel B., Ekici A.B., Salinas K., Gebhart E., Ruschendorf F., Sticht H., Spranger J., Muller D., Zweier C., Schmitt M.E., Reis A., Rauch A. Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator. Am. J. Hum. Genet. 2005, 77:795-806.
117. Verloes A., Pierard G.E., Le Merrer M., Maroteaux P. Recessive metaphyseal dysplasia without hypotrichosis. A syndrome clinically distinct from McKusick cartilage-hair hypoplasia. J. Med. Genet. 1990, 27:693-696.
118. Bonafe L., Schmitt K., Eich G., Giedion A., Superti-Furga A. RMRP gene sequence analysis confirms a cartilage-hair hypoplasia variant with only skeletal manifestations and reveals a high density of single-nucleotide polymorphisms. Clin. Genet. 2002, 61:146-151.
119. Menger H., Mundlos S., Becker K., Spranger J., Zabel B. An unknown spondylo-meta-epiphyseal dysplasia in sibs with extreme short stature. Am. J. Med. Genet. 1996, 63:80-83.
120. Horn D., Rupprecht E., Kunze J., Spranger J. Anauxetic dysplasia, a spondylometaepiphyseal dysplasia with extreme dwarfism. J. Med. Genet. 2001, 38:262-265.
121. Bowen P., Conradi G.J. Syndrome of skeletal and genitourinary anomalies with unusual facies and failure to thrive in Hutterite sibs. Birth Defects Orig. Artic. Ser. 1976, 12:101-108.
122. Lowry R.B., Innes A.M., Bernier F.P., McLeod D.R., Greenberg C.R., Chudley A.E., Chodirker B., Marles S.L., Crumley M.J., Loredo-Osti J.C., Morgan K., Fujiwara T.M. Bowen-Conradi syndrome: a clinical and genetic study. Am. J. Med. Genet. A 2003, 120A:423-428.
123. Armistead J., Khatkar S., Meyer B., Mark B.L., Patel N., Coghlan G., Lamont R.E., Liu S., Wiechert J., Cattini P.A., Koetter P., Wrogemann K., Greenberg C.R., Entian K.D., Zelinski T., Triggs-Raine B. Mutation of a gene essential for ribosome biogenesis, EMG1, causes Bowen-Conradi syndrome. Am. J. Hum. Genet. 2009, 84:728-739.
124. Bernstein K.A., Gallagher J.E., Mitchell B.M., Granneman S., Baserga S.J. The small-subunit processome is a ribosome assembly intermediate. Eukaryot. Cell 2004, 3:1619-1626.
125. Fromont-Racine M., Senger B., Saveanu C., Fasiolo F. Ribosome assembly in eukaryotes. Gene 2003, 313:17-42.
126. Tkaczuk K.L., Dunin-Horkawicz S., Purta E., Bujnicki J.M. Structural and evolutionary bioinformatics of the SPOUT superfamily of methyltransferases. BMC Bioinformatics 2007, 8:73.
127. Buchhaupt M., Meyer B., Kotter P., Entian K.D. Genetic evidence for 18S rRNA binding and an Rps19p assembly function of yeast nucleolar protein Nep1p. Mol. Genet. Genomics 2006, 276:273-284.
128. Bernstein K.A., Baserga S.J. The small subunit processome is required for cell cycle progression at G1. Mol. Biol. Cell 2004, 15:5038-5046.
129. Bernstein K.A., Bleichert F., Bean J.M., Cross F.R., Baserga S.J. Ribosome biogenesis is sensed at the Start cell cycle checkpoint. Mol. Biol. Cell 2007, 18:953-964.
130. Dez C., Tollervey D. Ribosome synthesis meets the cell cycle. Curr. Opin. Microbiol. 2004, 7:631-637.
131. Liu P.C., Thiele D.J. Novel stress-responsive genes EMG1 and NOP14 encode conserved, interacting proteins required for 40S ribosome biogenesis. Mol. Biol. Cell 2001, 12:3644-3657.
132. Eschrich D., Buchhaupt M., Kotter P., Entian K.D. Nep1p (Emg1p), a novel protein conserved in eukaryotes and archaea, is involved in ribosome biogenesis. Curr. Genet. 2002, 40:326-338.
133. Thiel C.T., Rauch A. The molecular basis of the cartilage-hair hypoplasia-anauxetic dysplasia spectrum. Best Pract. Res. Clin. Endocrinol. Metab. 2011, 25:131-142.
134. Xue S., Barna M. Specialized ribosomes: a new frontier in gene regulation and organismal biology. Nat. Rev. Mol. Cell Biol. 2012, 13:355-369.
135. Lindstrom M.S., Deisenroth C., Zhang Y. Putting a finger on growth surveillance: insight into MDM2 zinc finger-ribosomal protein interactions. Cell Cycle 2007, 6:434-437.
136. Rubbi C.P., Milner J. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J. 2003, 22:6068-6077.
137. Xu B., Lee K.K., Zhang L., Gerton J.L. Stimulation of mTORC1 with l-leucine rescues defects associated with Roberts Syndrome. PLoS Genet. 2013, 9:e1003857.